NCT05488314 2026-03-13METalmarkJanssen Research & Development, LLCPhase 1/2 Active not recruiting57 enrolled
NCT02335944 2023-06-18Study of Safety and Efficacy of EGFR-TKI EGF816 in Combination With cMET Inhibitor INC280 in Adult Patients With EGFR Mutated Non Small Cell Lung Cancer.NovartisPhase 1/2 Terminated177 enrolled 48 charts